Beurs gesloten -
OTC Markets
19:15:27 01-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,0014
USD
|
0,00%
|
|
0,00%
|
+16,67%
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
18,66
|
19,91
|
18,41
|
59,38
|
22,97
|
19,94
|
Bedrijfswaarde
1 |
19,12
|
19,72
|
18,51
|
59,98
|
22,9
|
21,09
|
K/w-verhouding
|
71,8
x
|
-7,75
x
|
-12,3
x
|
-39
x
|
-13,9
x
|
-11,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
329
x
|
286
x
|
240
x
|
774
x
|
299
x
|
260
x
|
Bedrijfswaarde/omzet
|
337
x
|
283
x
|
241
x
|
781
x
|
298
x
|
275
x
|
Bedrijfswaarde/EBITDA
|
-13,3
x
|
-14,9
x
|
-14,7
x
|
-46,4
x
|
-
|
-
|
Bedrijfswaarde/FCF
|
37,4
x
|
-10,4
x
|
-27,9
x
|
-115
x
|
-43,3
x
|
-46,3
x
|
FCF Yield
|
2,68%
|
-9,66%
|
-3,58%
|
-0,87%
|
-2,31%
|
-2,16%
|
Price to Book
|
-4,53
x
|
-9
x
|
-7,87
x
|
-21
x
|
-10,3
x
|
-5,79
x
|
Aantal aandelen (in duizenden)
|
1.098
|
1.284
|
1.315
|
1.334
|
1.435
|
1.435
|
Referentieprijs
2 |
17,00
|
15,50
|
14,00
|
44,50
|
16,00
|
13,89
|
Datum van publicatie
|
29/03/18
|
29/03/19
|
20/03/20
|
2/03/21
|
30/03/22
|
11/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
0,0567
|
0,0697
|
0,0768
|
0,0768
|
0,0768
|
0,0768
|
EBITDA
1 |
-1,442
|
-1,321
|
-1,26
|
-1,293
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-1,445
|
-1,323
|
-1,262
|
-1,295
|
-1,329
|
-1,402
|
Operationele Marge
|
-2.550,01%
|
-1.899,56%
|
-1.643,89%
|
-1.686,46%
|
-1.730,71%
|
-1.826,44%
|
Resultaat voor belastingen (EBT)
1 |
0,3851
|
-1,994
|
-1,404
|
-1,523
|
-1,598
|
-1,727
|
Nettowinst (verlies)
1 |
0,2865
|
-1,994
|
-1,404
|
-1,523
|
-1,598
|
-1,727
|
Nettomarge
|
505,7%
|
-2.861,55%
|
-1.829,35%
|
-1.984,56%
|
-2.081,47%
|
-2.250,43%
|
WPA
2 |
0,2369
|
-2,000
|
-1,135
|
-1,142
|
-1,153
|
-1,203
|
Free Cash Flow
1 |
0,5115
|
-1,906
|
-0,6632
|
-0,5213
|
-0,5284
|
-0,4558
|
FCF-marge
|
902,92%
|
-2.735,5%
|
-864%
|
-679,08%
|
-688,36%
|
-593,85%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
178,55%
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/03/18
|
29/03/19
|
20/03/20
|
2/03/21
|
30/03/22
|
11/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
0,45
|
-
|
0,1
|
0,6
|
-
|
1,16
|
Nettokaspositie
1 |
-
|
0,18
|
-
|
-
|
0,07
|
-
|
Hefboom (schuld/ebitda)
|
-0,3143
x
|
-
|
-0,0755
x
|
-0,4627
x
|
-
|
-
|
Free Cash Flow
1 |
0,51
|
-1,91
|
-0,66
|
-0,52
|
-0,53
|
-0,46
|
ROE (netto-inkomsten/eigen vermogen)
|
-5,63%
|
63%
|
61,7%
|
59%
|
63,2%
|
60,9%
|
ROA (netto-inkomsten/totale activa)
|
-166%
|
-326%
|
-159%
|
-128%
|
-90,4%
|
-105%
|
Totale activa
1 |
-0,1728
|
0,6123
|
0,8838
|
1,19
|
1,767
|
1,643
|
Nettoactief per aandeel
2 |
-3,750
|
-1,720
|
-1,780
|
-2,120
|
-1,550
|
-2,400
|
Cashflow per aandeel
2 |
0,1700
|
0,1800
|
0,4900
|
0,3200
|
0,8600
|
0,2000
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/03/18
|
29/03/19
|
20/03/20
|
2/03/21
|
30/03/22
|
11/04/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +16,67% | 2,11K | | -0,07% | 89,46 mld. | | +2,76% | 40,74 mld. | | -9,06% | 33,03 mld. | | +55,32% | 24,68 mld. | | -16,61% | 15,12 mld. | | -9,14% | 12,81 mld. | | -12,11% | 11,79 mld. | | -43,61% | 11,64 mld. | | +7,79% | 8,9 mld. |
Biofarmaceutica
|